Center for Neuroscience and Behavior
Center for Neuroscience and Behavior
Psychedelics Research and Treatments: The Current State of Research and Best Practices Guidance
Psychedelics Research and Treatments: The Current State of Research and Best Practices Guidance
Psychedelics Research and Treatments: The Current State of Research and Best Practices Guidance
Tuesday 27th August 2024
Explore the therapeutic potential of psychedelics with Dr. Matthew W. Johnson as he discusses their benefits, risks, and ethical considerations.
63 minutes
Informative
Educational
Hopeful
Honest
Non-judgmental
About this podcast
Author:
Center for Neuroscience and Behavior
Overview:
Categories:
Navigating Intimate Relationships
Mindfulness & Technology in Health
Holistic Health Innovations
Navigating Alcohol Dependency
Understanding Addiction & Recovery
Links:
Visit site
Episodes:
25 (View all)
Do you want to link to this podcast?
Get the buttons here!Psychedelics in Therapy: Insights from Dr. Matthew W. Johnson
Episode Overview
- Psychedelics show promise in treating conditions like depression, addiction, and PTSD.
- Safety and ethical considerations are crucial in psychedelics research.
- The FDA is currently evaluating MDMA for PTSD treatment.
- Microdosing lacks substantial evidence but is still under investigation.
- Future research aims to optimise psychedelic therapy methods.
We've never seen a convincing case where someone who's psychologically healthy can have a psychedelic experience and it makes them go mad
Ever wondered about the potential of psychedelics in treating mental health conditions? In this episode of Lobes and Robes, Dr. Matthew W. Johnson from the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics dives deep into the current state of psychedelics research. Dr. Johnson, a leading figure in the field, shares his extensive knowledge on how substances like psilocybin and MDMA are being explored as treatments for depression, addiction, PTSD, and more.
He also touches on the ethical considerations and safety practices essential for these studies. With over 20 years of experience, Dr. Johnson discusses his pioneering work and recent developments, including the FDA's stance on MDMA for PTSD treatment. You'll get a fascinating look at both the promises and pitfalls of psychedelics in modern medicine. Dr.
Johnson’s insights are backed by his numerous publications and media appearances, making this episode a must-listen for anyone curious about the future of mental health treatments. Tune in to hear about the potential life-changing benefits of psychedelics and the rigorous research that supports their use.